marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
GT Biopharma Cash Flow 2011-2024 | GTBP
Annual Cash Flow GT Biopharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-8.85 M | -15.2 M | -15.6 M | -7.26 M | -3.66 M | -10.7 M | -5.43 M | -1.93 M | -4.66 M | -1.75 M | -442 K | -987 K | -963 K |
Depreciation & Amortization |
- | - | - | - | 4 K | 7 K | 2 K | 1 K | 2 K | - | 2 K | 3 K | 23 K |
Accounts Payables |
4.33 M | 3.14 M | 8.19 M | 2.24 M | 1.94 M | 1.76 M | 2.55 M | 2.1 M | 893 K | 412 K | 940 K | 878 K | 806 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | 40 K | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | 42 K | 59 K | 12 K |
All numbers in USD currency
Quarterly Cash Flow GT Biopharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -4.16 M | - | - | - | -2.91 M | - | -10.9 M | -8 M | -5.22 M | - | -11.9 M | -7.97 M | -3.68 M | - | -5.34 M | -3.63 M | -223 K | - | -3.17 M | -2.05 M | -961 K | - | -9.43 M | -6 M | -4.23 M | - | -3.28 M | -1.04 M | -650 K | - | -1.8 M | -1.23 M | -167 K | - | -3.71 M | -3.08 M | -1.79 M | - | -711 K | -133 K | -90 K | - | -73 K | -118 K | -138 K | - | -773 K | -495 K | -192 K | - | -639 K | -540 K | -147 K |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10 K | 10 K | 1 K | - | 5 K | 2 K | 1 K | - | 2 K | 1 K | 1 K | - | 1 K | - | - | - | 1 K | 1 K | 1 K | - | - | - | - | - | 2 K | 1 K | - | - | 10 K | 9 K | 3 K | - | 20 K | 14 K | 7 K |
Accounts Payables |
2.61 M | 1.72 M | 3.21 M | 4.33 M | 3.97 M | 3.5 M | 3.13 M | 3.14 M | 3.32 M | 7.26 M | 8.11 M | 8.22 M | 2.8 M | 1.5 M | 2.38 M | 2.24 M | 2.24 M | 2.24 M | 2.24 M | 1.94 M | 1.94 M | 1.94 M | 1.94 M | 1.76 M | 1.76 M | 1.76 M | 1.76 M | 2.55 M | 2.55 M | 2.55 M | 2.55 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 893 K | 893 K | 893 K | 893 K | 412 K | 412 K | 412 K | 412 K | 940 K | 940 K | 940 K | 940 K | 878 K | 878 K | 878 K | 878 K | 806 K | 806 K | 806 K | 806 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5 K | 30 K | 40 K | 40 K | 40 K | 40 K | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 26 K | 26 K | 42 K | 42 K | 42 K | 42 K | 42 K | 59 K | 59 K | 59 K | 59 K | 12 K | 12 K | 12 K | 12 K |
All numbers in USD currency